VeriMompeg-4 stearamide hamilelikte güvenli mi?
No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety opinion specifically identifying reproductive hazard, and no peer-reviewed reports of teratogenicity or human reproductive effects for PEG-4 stearamide were found in available regulatory sources; therefore default hazard and mechanism scores are 0. Dermal absorption for small PEGylated surfactants/emollients is low but measurable in topical use, so exposure scored as low (e=1). Sources consulted: ECHA Annex VI (no harmonised classification), CIR database (no safety assessment for this specific INCI), PubChem/CosIng entries (no reproductive flags).
Related ingredients
Frequently asked questions
- peg-4 stearamide hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety opinion specifically identifying reproductive hazard, and no peer-reviewed reports of teratogenicity or human reproductive effects for PEG-4 stearamide were found in available regulatory sources; therefore default hazard and mechanism scores are 0. Dermal absorption for small PEGylated surfactants/emollients is low but measurable in topical use, so exposure scored as low (e=1). Sources consulted: ECHA Annex VI (no harmonised classification), CIR database (no safety assessment for this specific INCI), PubChem/CosIng entries (no reproductive flags).
- peg-4 stearamide emzirirken güvenli mi?
- Same rationale as pregnancy: no reproductive or lactation-specific hazards identified in regulatory databases or peer-reviewed sources. Low but measurable dermal absorption assumed for topical use; systemic transfer into breastmilk is not documented for this ingredient. Sources: PubChem, CosIng, ECHA (no harmonised classification), no CIR/SCCS concerns found.
- peg-4 stearamide bebek cildi için güvenli mi?
- No infant-specific reproductive or developmental toxicity data were identified. Following the instruction to increase exposure score by +1 for baby skin when adult dermal absorption is measurable, exposure is increased to moderate (e=2) because infants have thinner/immature barrier and higher surface-area-to-weight ratio. No evidence supports raising hazard or mechanism scores in infants. Sources: CosIng/PubChem (ingredient identity and use), absence of ECHA Annex VI harmonised flags or CIR/SCCS adverse findings.
- VeriMom peg-4 stearamide nasıl puanlıyor?
- VeriMom peg-4 stearamide'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte peg-4 stearamide yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.